This treatment pilot study will investigate clinical efficacy and adverse effects of magnetic seizure therapy (MST) in patients currently experiencing a unipolar or bipolar depressive episode. The investigators will perform add-on tests to assess clinical and cognitive response to treatment. It is hypothesized that MST will have an antidepressant efficacy with a beneficial neurocognitive adverse effect profile.
Study Type
INTERVENTIONAL
Allocation
NON_RANDOMIZED
Purpose
TREATMENT
Masking
NONE
Enrollment
32
antidepressant treatment with MST
Department of Psychiatry, CC15, CBF, Eschenallee 3
Berlin, Germany
Clinical Improvement (HAMD)
Time frame: before, after treatment
Neurocognitive performance
Time frame: before/after treatment
This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.